Search Results 11-20 of 17221 for Uveitis
The purpose of this study is to evaluate the efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis.
Clinical Trials · A Study Of Brepocitinib In Adults With Active, Non-Infectious, Non-Anterior Uveitis · More about research at Mayo Clinic · Mayo Clinic Footer.
Uveitis related to systemic disease such as sarcoidosis or Behcets Disease; Immunotherapy-related uveitis; Infectious uveitis; Scleritis. Dr. Smith feels that ...
Uveitis — which is inflammation of the middle layer of the eye. Other conditions. Allergies; Chalazion — caused by clogged oil glands on the eyelid. Cluster ...
A Study of the Safety and Effectiveness of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution for Non-Infectious Anterior Uveitis · Overview.
Addressing challenging uveitis cases through collaboration and tailored therapies. Recognizing that uveitis often reflects underlying systemic autoimmune or ...
A Study Assessing the Effectiveness and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the ...
Uveitis is inflammation in the middle layer of tissue in the eye wall (uvea). Posterior uveitis affects the back of the eye, which includes the retina and ...
A Study to Assess the Effectiveness and Safety of Intravitreal 440 ug DE-109 Sirolimus Injections for the Treatment of Active, Non-Infectious Uveitis of the ...
The most common ocular disease was uveitis (61 percent), followed by dry eye disease, conjunctival nodule, episcleritis, anterior scleritis and conjunctivitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.